Effects of estrogen, an ERα agonist and raloxifene on pressure overload induced cardiac hypertrophy.
The aim of this study was to investigate the effects of 17β-estradiol (E2), the selective ERα agonist 16α-LE2, and the selective estrogen receptor modulator (SERM) raloxifene on remodeling processes during the development of myocardial hypertrophy (MH) in a mouse model of pressure overload. Myocardi...
Main Authors: | Christina Westphal, Carola Schubert, Katja Prelle, Adam Penkalla, Daniela Fliegner, George Petrov, Vera Regitz-Zagrosek |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3515519?pdf=render |
Similar Items
-
Sex differences and estrogen effects in cardiac mitochondria in human aortic stenosis and in the mouse heart
by: Daniela Fliegner, et al.
Published: (2023-10-01) -
Sex-specific regulation of cardiac microRNAs targeting mitochondrial proteins in pressure overload
by: Hugo Sanchez-Ruderisch, et al.
Published: (2019-02-01) -
Antileishmanial activity of the estrogen receptor modulator raloxifene.
by: Juliana Q Reimão, et al.
Published: (2014-05-01) -
The selective estrogen receptor modulator raloxifene inhibits neutrophil extracellular trap formation.
by: Roxana Flores, et al.
Published: (2016-12-01) -
CYP2J2 overexpression protects against arrhythmia susceptibility in cardiac hypertrophy.
by: Christina Westphal, et al.
Published: (2013-01-01)